127 related articles for article (PubMed ID: 6304555)
1. On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.
Barbaccia ML; Brunello N; Chuang DM; Costa E
Neuropharmacology; 1983 Mar; 22(3 Spec No):373-83. PubMed ID: 6304555
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
Gandolfi O; Roncada P; Dall'Olio R
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):941-52. PubMed ID: 2554363
[TBL] [Abstract][Full Text] [Related]
3. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
Gandolfi O; Barbaccia ML; Costa E
J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
[TBL] [Abstract][Full Text] [Related]
4. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
5. (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.
Zsilla G; Barbaccia ML; Gandolfi O; Knoll J; Costa E
Eur J Pharmacol; 1983 Apr; 89(1-2):111-7. PubMed ID: 6305680
[TBL] [Abstract][Full Text] [Related]
6. The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.
Gandolfi O; Barbaccia ML; Costa E
Eur J Pharmacol; 1984 Apr; 100(2):233-7. PubMed ID: 6329776
[TBL] [Abstract][Full Text] [Related]
7. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
Barbaccia ML; Gandolfi O; Chuang DM; Costa E
Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
[TBL] [Abstract][Full Text] [Related]
8. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
Gandolfi O; Barbaccia ML; Costa E
Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
[TBL] [Abstract][Full Text] [Related]
9. Effect of methiothepin on imipramine- or mianserin- induced subsensitivity of serotonergic receptors.
Segawa T; Uehara M
Life Sci; 1982 Mar; 30(10):809-12. PubMed ID: 7070196
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
Dumbrille-Ross A; Tang SW
Psychiatry Res; 1983 Jul; 9(3):207-15. PubMed ID: 6312480
[TBL] [Abstract][Full Text] [Related]
11. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
Kinnier WJ; Chuang DM; Costa E
Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
[TBL] [Abstract][Full Text] [Related]
12. Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions.
Racagni G; Mocchetti I; Calderini G; Battistella A; Brunello N
Neuropharmacology; 1983 Mar; 22(3 Spec No):415-24. PubMed ID: 6304559
[TBL] [Abstract][Full Text] [Related]
13. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic mechanism in imipramine induced antinociception in rat tail flick test.
Bhargava VK; Saha L
Indian J Physiol Pharmacol; 2001 Jan; 45(1):107-10. PubMed ID: 11211562
[TBL] [Abstract][Full Text] [Related]
15. The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats.
Friedman E; Cooper T; Yocca F
Eur J Pharmacol; 1986 Apr; 123(3):351-6. PubMed ID: 3013651
[TBL] [Abstract][Full Text] [Related]
16. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
17. Imipramine alters beta-adrenergic, but not serotonergic, mediated responses in rat hippocampal pyramidal cells.
Beck SG; Halloran PM
Brain Res; 1989 Dec; 504(1):72-81. PubMed ID: 2557127
[TBL] [Abstract][Full Text] [Related]
18. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression.
Papp M; Klimek V; Willner P
Psychopharmacology (Berl); 1994 Mar; 114(2):309-14. PubMed ID: 7838924
[TBL] [Abstract][Full Text] [Related]
19. 3H-imipramine binding sites in brain down-regulated by chronic nortriptyline and haloperidol but not mianserin treatment.
Hrdina PD
Psychiatry Res; 1984 Apr; 11(4):271-8. PubMed ID: 6588395
[TBL] [Abstract][Full Text] [Related]
20. Different synaptic location of mianserin and imipramine binding sites.
Brunello N; Chuang DM; Costa E
Science; 1982 Feb; 215(4536):1112-5. PubMed ID: 6278586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
